These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 4883020

  • 1. [Cause of hyperlipemia in nephrotic syndrome].
    Yoshitoshi Y, Naito C.
    Nihon Rinsho; 1968 May; 26(5):1106-16. PubMed ID: 4883020
    [No Abstract] [Full Text] [Related]

  • 2. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV.
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract] [Full Text] [Related]

  • 3. Biochemical anomalies of the nephrotic syndrome.
    Lewith G, Gabriel R.
    Curr Med Res Opin; 1975 Dec; 3(4):199-202. PubMed ID: 168035
    [Abstract] [Full Text] [Related]

  • 4. [Hyperlipemia in nephrotic syndrome].
    Walasek L.
    Pol Tyg Lek; 1972 Jan 31; 27(5):189-91. PubMed ID: 4551652
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Some aspects of hyperlipemia in the nephrotic syndrome].
    Guarini G, Costa C, Leri O, Cerulli C.
    Minerva Nefrol; 1975 Jan 31; 22(1):54-7. PubMed ID: 1207973
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM, Vega GL.
    Am J Med; 1989 Nov 31; 87(5N):3N-11N. PubMed ID: 2486542
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperlipidemia of the nephrotic syndrome.
    Kaysen GA.
    Kidney Int Suppl; 1991 Apr 31; 31():S8-15. PubMed ID: 2046275
    [No Abstract] [Full Text] [Related]

  • 12. [Mutual relation between hyperlipidemia and nephrotic syndrome].
    Kraise Y, Averbuch M, Schwartz D, Kornovsky R, Levo Y.
    Harefuah; 1991 Dec 15; 121(12):521-4. PubMed ID: 1794760
    [No Abstract] [Full Text] [Related]

  • 13. [Lipid metabolism in kidney diseases].
    Yoshitoshi Y, Naito C.
    Naika; 1968 Oct 15; 22(4):824-30. PubMed ID: 4884620
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.
    Gomperts ED, Zucker M, Feesey M, Russel D, Salant D, Joffe BI, Mendelsohn D, Seftel H.
    J Lab Clin Med; 1977 Sep 15; 90(3):529-35. PubMed ID: 578151
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of hyperlipidemia in nephrotic syndrome: time for a change?
    Olbricht CJ, Koch KM.
    Nephron; 1992 Sep 15; 62(2):125-9. PubMed ID: 1436302
    [No Abstract] [Full Text] [Related]

  • 16. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome].
    Campanacci L, Guarnieri GF, Faccini L, Bellini G, Gambari PF.
    G Clin Med; 1973 Oct 15; 54(10):714-33. PubMed ID: 4789301
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Dyslipidemia in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
    Campanacci L.
    Minerva Nefrol; 1975 Oct 15; 22(6):243-51. PubMed ID: 1223701
    [No Abstract] [Full Text] [Related]

  • 20. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E.
    Isr J Med Sci; 1996 Jun 15; 32(6):390-7. PubMed ID: 8682644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.